Introduces India as a leading pharmaceutical company due to its well-trained workforce, modern infrastructure, and cost-effective production. It also mentions India’s position in the manufacture of biosimilars and the country’s large economy as a factor in its success.
Discusses the advantages of third-party pharma manufacturing in India and how each of the characteristics mentioned in paragraph 1 is present in these companies.
Talks about India’s market size and how it has emerged as a popular option for collaborations with Western firms due to the rapid growth in demand for foreign-made medicines. It also discusses the low cost of generic medicines in India and how the Indian government runs its pharmacy network to ensure citizens have access to affordable medicines.
Explores how the low price of medicines in India is due to the fierce competition and growth of Indian pharmaceutical manufacturing companies. It also mentions other advantages such as inexpensive energy, affordable property values, cheap labour costs, and affordable technology.
Discusses how pharma production companies in India have made large investments to modernize their infrastructure and bring it in line with international standards.
Concludes by mentioning how Western businesses can benefit from collaborating with local drug makers in India to satisfy the growing demand for affordable medical services, which will greatly benefit countries like the US and Europe.